232 related articles for article (PubMed ID: 36301456)
1. Guanxin Danshen Dripping Pills Improve Quality of Life and Cardiovascular Prognoses of CHD Patients after PCI with Anxiety or Depression (GLAD Study): A Randomized Double-Blind Placebo-Controlled Study.
Wang CL; Huan N; Wang PL; Geng QS; Ma WL; Ma LH; Jiang HY; Meng XP; Zhang DW; Gou XJ; Hu DY; Chen KJ
Chin J Integr Med; 2023 Mar; 29(3):195-204. PubMed ID: 36301456
[TBL] [Abstract][Full Text] [Related]
2. Effect of Guanxin Danshen Dripping Pills on Coronary Heart Disease Comorbid with Depression or Anxiety: The ADECODE-Real World Study.
Wu SH; Shi WQ; Li YH; Liu RH; Hu DY; Zheng LQ; Ma WL
Chin J Integr Med; 2024 May; 30(5):443-448. PubMed ID: 37947990
[TBL] [Abstract][Full Text] [Related]
3. [Meta-analysis of effect of Qishen Yiqi Dripping Pills combined with Western medicine on adverse cardiovascular events and quality of life after percutaneous coronary intervention].
Dai QQ; Shi ZF; Hu JY; Han SJ; Zhong CM; Guan MK; Tian GH; Shang HC
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(6):1498-1510. PubMed ID: 33787149
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of
Wu T; Li S; Li Z; Long W; Liu Q; Tang H; Huang X; Tang Y; Dong X; Ning Y; Tian S; Xu T; Xian SX; Liao H; Hong Y; Yang Z
BMJ Open; 2023 May; 13(5):e055263. PubMed ID: 37164472
[TBL] [Abstract][Full Text] [Related]
5. Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
Shen Z; Chen T; Deng B; Fan M; Hua J; Zhang M; Wang X
J Altern Complement Med; 2020 Nov; 26(11):1055-1063. PubMed ID: 32716206
[No Abstract] [Full Text] [Related]
6. Effect of Shenzhu Guanxin Recipe () on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial.
Xu DP; Wu HL; Lan TH; Wang X; Sheng XG; Lin Y; Li S; Zheng CY
Chin J Integr Med; 2015 Jun; 21(6):408-16. PubMed ID: 26063318
[TBL] [Abstract][Full Text] [Related]
7. [Trial study on DENG Tie-tao's coronary heart disease capsules in improving patients' quality of life].
Wu HL; Wang X; Li XM; Luo WJ; Deng TT
Chin J Integr Med; 2005 Sep; 11(3):173-8. PubMed ID: 16181529
[TBL] [Abstract][Full Text] [Related]
8. Effect of Xuefu Zhuyu Capsule (血府逐瘀胶囊) on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: A Randomized controlled trial.
Chu FY; Wang J; Yao KW; Li ZZ
Chin J Integr Med; 2010 Oct; 16(5):399-405. PubMed ID: 20535581
[TBL] [Abstract][Full Text] [Related]
9. Effect of shenshao tablet on the quality of life for coronary heart disease patients with stable angina pectoris.
Wang J; He QY; Zhang YL
Chin J Integr Med; 2009 Oct; 15(5):328-32. PubMed ID: 19802534
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness and safety of Chinese Patent Medicines based on syndrome differentiation in patients following percutaneous coronary intervention due to acute coronary syndrome (CPM trial): A nationwide Cohort Study.
Bai R; Yang Q; Xi R; Che Q; Zhao Y; Guo M; Dong G; Gao Z; Fu C; Wang P; Gu F; Du J; Zhang D; Duan W; Li L; Shi D
Phytomedicine; 2023 Jan; 109():154554. PubMed ID: 36610159
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety evaluation of Ginkgo biloba dropping pill (GBDP) on stable angina pectoris complicated with depression: A placebo-controlled, randomized, double-blind, multicenter study.
He X; Liu D; Ni S; Li Z; Li S; Wu T; Dong X; Zhang X; Tang Y; Ling Y; Liao H; Kang J; Li Y; Wu H; Luo J; Wan X; Zhang D; Lu L; Long W; Yang Z
Phytomedicine; 2024 Apr; 126():155264. PubMed ID: 38430820
[TBL] [Abstract][Full Text] [Related]
12. [A randomized double-blinded controlled trial of Xuefu Zhuyu Capsule on short-term quality of life in unstable anginal patients with blood-stasis syndrome after percutaneous coronary intervention].
Chu FY; Wang J; Sun XW; Xing YW; Yao KW; Wang SH; Li ZZ
Zhong Xi Yi Jie He Xue Bao; 2009 Aug; 7(8):729-35. PubMed ID: 19671410
[TBL] [Abstract][Full Text] [Related]
13. Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
Zheng GH; Liu JP; Chu JF; Mei L; Chen HY
Cochrane Database Syst Rev; 2013 May; (5):CD009581. PubMed ID: 23728695
[TBL] [Abstract][Full Text] [Related]
14. A traditional Chinese medicine therapy for coronary heart disease after percutaneous coronary intervention: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Chen R; Xiao Y; Chen M; He J; Huang M; Hong X; Liu X; Fu T; Zhang J; Chen L
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30143584
[TBL] [Abstract][Full Text] [Related]
15. Effects of Xinkeshu tablets on coronary heart disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A meta-analysis.
Chen M; Liu M; Guo X; Zhou J; Yang H; Zhong G; Men L; Xie Y; Tong G; Liu Q; Luan J; Zhou H
Phytomedicine; 2022 Sep; 104():154243. PubMed ID: 35717809
[TBL] [Abstract][Full Text] [Related]
16. Combination of Activating Blood Circulation and Detoxifying Chinese Medicines Played an Anti-Inflammatory Role in Unstable Angina Patients after Percutaneous Coronary Intervention: A Multicenter, Open-Labeled, Randomized Controlled Trial.
Ma XJ; Duan WH; Zhang Y; Gao J; Guan BY; Chen KJ; Shi DZ
Chin J Integr Med; 2021 Nov; 27(11):803-810. PubMed ID: 34532749
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of Xinkeshu on coronary artery disease patients combined with anxiety and depression symptoms after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
Chen M; Zhong G; Men L; Liu Q; Luan J
Medicine (Baltimore); 2021 Nov; 100(46):e27912. PubMed ID: 34797346
[TBL] [Abstract][Full Text] [Related]
18. Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial.
Guo M; Zi MJ; Xi RX; Yang QN; Bai RN; Zhang YS; Wang YH; Wang PL; Shi DZ
Trials; 2016 Aug; 17():412. PubMed ID: 27538952
[TBL] [Abstract][Full Text] [Related]
19. Tong-xin-luo capsule for patients with coronary heart disease after percutaneous coronary intervention.
Mao C; Fu XH; Yuan JQ; Yang ZY; Chung VC; Qin Y; Huang Y; Tam WW; Kwong JS; Xie W; Tang JL
Cochrane Database Syst Rev; 2015 May; (5):CD010237. PubMed ID: 25994229
[TBL] [Abstract][Full Text] [Related]
20. Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis.
Lv L; Yuan X; Jiang L
Medicine (Baltimore); 2022 Feb; 101(8):e28994. PubMed ID: 35212312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
